Bloomberg Television
@markets·3.2M subscribers·95.6K videos
US Threatens 250% Rise in Pharma Tariffs, India Tariff Blitz | The Opening Trade 8/6/2025
Posted
August 6, 2025
Views
6,578
Likes
68
Comments
36
Engagement
August 6, 2025
6,578
68
36
1.58%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
1:35:33Now PlayingComing just days after Trump re-set his tariff plan with rates on imports from trade partners ranging from 10% to 41%, his latest blast of trade threats and deadlines shows his quest to remake global trade in America’s favor is far from done. That’s even as the latest economic data suggests the US economy is grappling with the fallout.
“We’ll be putting a initially small tariff on pharmaceuticals, but in one year — one and a half years, maximum — it’s going to go to 150% and then it’s going to go to 250% because we want pharmaceuticals made in our country,” Trump said Tuesday in the interview on CNBC.
The Opening Trade has everything you need to know as markets open across Europe. With analysis you won't find anywhere else, we break down the biggest stories of the day and speak to top guests who have skin in the game. Hosted by Kriti Gupta, Valerie Tytel and Oliver Crook.
Chapters:
--------
More on Bloomberg Television and Markets
Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance
Visit for business news & analysis, uptotheminute market data, features, profiles and more.
Connect with Bloomberg Television on:
Connect with Bloomberg Business on:
More from Bloomberg:
Bloomberg Radio
Bloomberg Surveillance
Bloomberg Politics
Bloomberg Originals
Watch more on YouTube:
Bloomberg Technology
Bloomberg Originals
Bloomberg Quicktake
Bloomberg Espanol
Bloomberg Podcasts
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
